<DOC>
	<DOCNO>NCT02641925</DOCNO>
	<brief_summary>Many feature metabolic syndrome associate insulin resistance . And , metabolic syndrome insulin resistance related visceral obesity . Therefore , investigator hypothesize visceral fat removal ( omentectomy ) make favorable result insulin resistance metabolic syndrome . As omentectomy optional procedure surgery early gastric cancer , investigator divide patient randomly two group , total omentectomy group omentum preserve group .</brief_summary>
	<brief_title>Omentectomy Metabolic Syndrome Gastric Cancer Patients</brief_title>
	<detailed_description>The investigator compare change insulin resistance ( HOMA-IR ) improvement metabolic syndrome total omentectomy omentum preserve group .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Histologically confirm adenocarcinoma stomach Aged≥20 year ≤80 year Scheduled laparoscopic distal gastrectomy ( cT1N0M0 cT2N0M0 ) Metabolic syndrome ( NCEP : ATP III ( National Cholesterol Education Program Adult Treatment Panel III ) harmonize definition criterion ECOG 0 ( Eastern Cooperative Oncology Group ) ASA score class IIII ( American Society Anesthesiologists ) patient give write informed consent participate study Simultaneously combine resection organ Active malignancy Expected severe intraabdominal adhesion due previous abdominal operation history Uncontrolled comorbidity Vulnerable patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Metabolic syndrome</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>omentectomy</keyword>
</DOC>